October 8, 2015
US FDA announces updated drug shortages list
U.S. Food & Drug Administration (FDA) has updated information on Drug Shortages.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
October 8, 2015
Verona Pharma welcomes new directors to the company
Verona Pharma plc, a London-listed drug development company focused on medicines to treat respiratory diseases, has appointed new Non-Executive Directors of the Company
October 8, 2015
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib in Advanced Breast Cancer
Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to…
October 8, 2015
Merck and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma
Merck KGaA and Pfizer have announced that the US Food and Drug Administration (FDA) has granted avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Fast Track designation for the treatment of metastatic Merkel cell carcinoma (MCC), a rare and aggressive type of skin cancer.
October 8, 2015
Novartis:Long-term efficacy of Gilenya
Novartis has announced a new analysis from the phase III FREEDOMS and FREEDOMS II trials reinforcing the long-term efficacy profile of Gilenya (fingolimod).
October 8, 2015
Sanofi and Genzyme:positive investigational data from the extension study of Lemtrada
Sanofi and its subsidiary Genzyme announced positive new five-year investigational data from the extension study of Lemtrada (alemtuzumab) for patients with relapsing remitting multiple sclerosis (RRMS).
October 6, 2015
VIDEO – Take a look at the U.S. government’s response in addressing Ebola in the United States.
Watch a video and take a look at the U.S. government’s response in addressing Ebola in the United States.
October 6, 2015
Teva’s acquisition of Rimsa
Teva Pharmaceutical Industries Ltd. has announced that it has entered into definitive agreements under which the Company will acquire Representaciones e Investigaciones Médicas, S.A. de C.V. (Rimsa), a pharmaceutical manufacturing and distribution company in Mexico
October 5, 2015
FDA orders three duodenoscopes manufacturers marketed in US
The U.S. Food and Drug Administration ordered on Monday the three manufacturers of duodenoscopes marketed in the U.S. to conduct postmarket surveillance studies to better understand how the devices are reprocessed in real-world settings.
October 5, 2015
J&J divestitutes Cordis to Cardinal Health for $2 billion
Johnson & Johnson has completed the divestiture of its Cordis business to Cardinal Health for an approximate value of $2 billion.